首页> 外文期刊>Medical Devices: Evidence and Research >Deep sedation for endoscopic retrograde cholangiopancreatography: a comparison between clinical assessment and NarcotrendTM monitoring
【24h】

Deep sedation for endoscopic retrograde cholangiopancreatography: a comparison between clinical assessment and NarcotrendTM monitoring

机译:内镜逆行胰胆管造影的深层镇静:临床评估与NarcotrendTM监测的比较

获取原文
           

摘要

Introduction: Moderate to deep sedation is generally used for endoscopic retrograde cholangiopancreatography (ERCP). The depth of sedation is usually judged by clinical assessment and electroencephalography-guided monitoring. The aim of this study was to compare the clinical efficacy of clinical assessment and NarcotrendTM monitoring during deep-sedated ERCP.Methods: One hundred patients who underwent ERCP in a single year were randomly assigned to either group C or group N. Patients in group C (52) were sedated using the Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) scale. Patients in group N (48) were sedated using the NarcotrendTM system. The MOAA/S scale 1 or 2 and the NarcotrendTM index 47–56 to 57–64 were maintained during the procedure. The primary outcome variable of the study was the successful completion of the endoscopic procedure. The secondary outcome variables were the total dose of propofol used during the procedure, complications during and immediately after procedure, and recovery time.Results: All endoscopies were completed successfully. The mean total dose of propofol in group C was significantly lower than that in group N. However, the mean dose of propofol, expressed as dose/kg or dose/kg/h in both groups, was not significantly different (P = 0.497, 0.136). Recovery time, patient tolerance and satisfaction, and endoscopist satisfaction were comparable between the two groups. All sedation-related adverse events during and immediately after the procedure, such as hypotension, hypertension, tachycardia, bradycardia, transient hypoxia, and upper airway obstruction, in group C (62.2%) were significantly higher than in group N (37.5%) (P = 0.028).Conclusion: Clinical assessment and NarcotrendTM-guided sedation using propofol for deep sedation demonstrated comparable propofol dose and recovery time. Both monitoring systems were equally safe and effective. However, the NarcotrendTM-guided sedation showed lower hemodynamic changes and fewer complications compared with the clinical assessment-guided sedation.
机译:简介:中度至深度镇静通常用于内镜逆行胰胆管造影(ERCP)。镇静深度通常通过临床评估和脑电图引导监测来判断。这项研究的目的是比较深层ERCP期间临床评估和NarcotrendTM监测的临床疗效。方法:将100名一年内接受ERCP的患者随机分为C组或N组.C组患者(52)使用改良的观察者的警觉/镇静评估量表(MOAA / S)进行镇静。 N组(48)的患者使用NarcotrendTM系统镇静。手术期间维持MOAA / S评分1或2和NarcotrendTM指数47-56至57-64。该研究的主要结果变量是成功完成内窥镜检查程序。次要结果变量是手术过程中使用的异丙酚总剂量,手术过程中和手术后的并发症以及恢复时间。结果:所有内镜检查均已成功完成。 C组丙泊酚的平均总剂量显着低于N组。但是,两组的异丙酚平均剂量(以剂量/千克或剂量/千克/小时表示)没有显着差异(P = 0.497, 0.136)。两组的恢复时间,患者的耐受性和满意度以及内镜医师的满意度相当。 C组(62.2%)在手术过程中和手术后立即发生的与镇静有关的所有不良事件,如低血压,高血压,心动过速,心动过缓,短暂性缺氧和上呼吸道阻塞,均显着高于N组(37.5%)( P = 0.028)。结论:临床评估和NarcotrendTM指导的使用丙泊酚进行深度镇静的镇静剂显示丙泊酚的剂量和恢复时间相当。两种监测系统都同样安全有效。但是,与临床评估指导的镇静相比,NarcotrendTM指导的镇静显示出较低的血液动力学变化和较少的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号